Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
30.83 Up 0.52(1.72%) Jul 11, 4:00PM EDT
Prev Close:30.31
Open:30.42
Bid:30.50 x 500
Ask:30.89 x 500
1y Target Est:43.56
Beta:1.63
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:30.12 - 31.17
52wk Range:22.25 - 62.66
Volume:1,209,797
Avg Vol (3m):2,894,590
Market Cap:3.62B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISUp 1.72%3.62B
ENZUp 2.77%227.90M
GILDDown 0.24%136.26B
SRPTDown 2.48%894.10M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.71
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-1.85

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback